Piperlongumine effectively prevents colon cancer by targeting Ras protein and PI3K/Akt signaling cascade to suppress the activity of Akt/NF-κB, c-Myc and cell cycle protein D1 (40). The gene discussed is AKT1; the disease is malignant colon neoplasm.